Boyd W Hendrickson
CIK 1316784 · CEO · last filed 2024-05-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.05M
Companies
2
Total Filings
54
Lifetime Open-Market Net
-$3.22M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LTC | Director | 25,110 | $41.77 | $1.05M | -$1.65M | 30 | 2024-05-24 |
| Genesis Healthcare, Inc. (SKH) Delisted | CEO | 314,904 | — | — | -$1.57M | 22 | 2013-11-15 |
Recent Filings · Page 4 of 6
54 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-06-26 | LTC | Mixed | — | -$108.6K | EDGAR |
| 2012-05-24 | LTC | Grant (A) | +2,000 | $63.7K | EDGAR |
| 2012-05-04 | Genesis Healthcare, Inc. (SKH) Delisted | Sell (S) | −40,000 | -$322.9K | EDGAR |
| 2012-02-17 | Genesis Healthcare, Inc. (SKH) Delisted | Mixed | +113,531 | -$140.1K | EDGAR |
| 2011-12-07 | LTC | Sell (S) | −3,000 | -$61.8K | EDGAR |
| 2011-06-03 | LTC | Grant (A) | +1,500 | $43.0K | EDGAR |
| 2011-02-18 | Genesis Healthcare, Inc. (SKH) Delisted | Grant (A) | +69,930 | $0 | EDGAR |
| 2011-02-15 | Genesis Healthcare, Inc. (SKH) Delisted | Tax (F) | −14,086 | -$182.4K | EDGAR |
| 2010-12-17 | Genesis Healthcare, Inc. (SKH) Delisted | Sell (S) | −1,400 | -$11.2K | EDGAR |
| 2010-09-01 | LTC | Sell (S) | −5,333 | -$131.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.